Key result
Obesity exacerbates the chronic inflammation and prothrombotic state induced by SARS-CoV-2 infection, further increasing the risk of ischemic stroke in COVID-19 patients.
Why the study?
Prior studies examined correlations between COVID-19, ischemic stroke, and obesity, but the mechanism of thrombosis in obese COVID-19 patients remains elusive.
Obesity exacerbates the inflammatory and prothrombotic state induced by COVID-19, increasing the risk of ischemic stroke through mechanisms involving ACE-2 receptor binding and cytokine storm.
May heighten stroke vigilance in obese COVID-19 patients; hypothesis-generating and requires prospective validation.
Highlight: The ongoing Coronavirus disease 2019 also affects multiorgan, including cardiovascular disease with several factors. Mechanism of thrombus in the patient that induces the subject such as obesity with increased BMI, thrombotic pathway modulator and pathophysiologist. An increase in acute CVD incidence, including ischemic stroke in COVID-19 patients, has been a new concern in the ongoing pandemic. ABSTRACT Coronavirus disease 2019 (COVID-19), despite being a respiratory infection, also causes neurological manifestations such as stroke due to thrombosis formation. Prior investigations have examined the correlation between COVID-19 and ischemic stroke, as well as COVID-19 and obesity. However, the mechanism of thrombosis in obese COVID-19 patients remains elusive. This review aims to examine the mechanism of thrombosis in COVID-19 patients with ischemic stroke and obesity. Chronic inflammation and impaired fibrinolysis are two major pathways responsible for thrombosis in people with obesity. Chronic inflammation activates prothrombic signaling pathways in vascular cells, resulting in procoagulant factors and adhesion molecules upregulation, anticoagulant proteins downregulation, platelet activation enhancement, and increased thrombin generation. SARS-CoV-2 enters human cells utilizing the angiotensin-converting enzyme 2 (ACE-2) receptors, which results in inflammation, which has been suggested as one of the factors contributing to thrombotic complications in COVID-19 patients. The infection also causes cytokine storm that induces atherosclerosis, plaque rupture, and superimposed thrombosis leading to brain damage. Together with endothelial injury, the cytokine storm might increase the expression of tissue factors and further promote a prothrombic state. In conclusion, the mechanisms of thrombosis in COVID-19 patients are related to direct infection of SARS-CoV-2 into the ACE-2 receptor and the cytokine storm that results in chronic inflammation and thrombosis formation. Obesity will further boost the inflammation process that leads to the formation of thrombosis and increase the risk of ischemic stroke among individuals with COVID-19 with obesity.
No takes yet. Share an insight, caveat, or question.
Winanda et al. (2022) conducted a review in COVID-19, Obesity, Ischemic Stroke. COVID-19 and Obesity was evaluated. Obesity exacerbates the chronic inflammation and prothrombotic state induced by SARS-CoV-2 infection, further increasing the risk of ischemic stroke in COVID-19 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: